甲流记忆与思考 历史上的流感大流行  

H1N1 Influenza:Memory and Reflection

作　　者：于丽[1] 宋姗姗[1] 

机构地区：[1]《中国处方药》编辑部

出　　处：《中国处方药》2010年第4期22-23,共2页Journal of China Prescription Drug

摘　　要：尽管2月25日WHO决定维持目前甲型H1N1流感处于大流行阶段的警戒级别,但从发病率来看,甲流患者占流感患者的比例已从1月份的36%下降到2月份的不到20%,死亡率也并不比普通流感高。在各国政府的强效干预下,此次甲流疫情正在离我们远去。人类防控流感大流行的能力已再次得到证明,然而新的命题考验又摆在了我们面前:快速审批上市的甲流疫苗其长期安全性如何?现有的抗病毒药物如果出现耐药,我们是否有更好的药物应对?在甲流疫情初步得以控制的喜悦背后,还有很多问题需要我们思考。WHO decided to maintain global alert and response(GAR) for pandemic A(H1N1) on February 25th,2010,however,from the view of incidence,patients infected with influenza H1N1 accounted for less than 20% of all the patients infected with influenza,compared with the proportion of 30% in the last January,and the mortality of the patients infected with H1N1 influenza was not higher than that of seasonal influenza.With the strong intervention of governments of various countries,the pandemic A(H1N1) seems to gradually go away from us.Prevention and control capacity for human influenza pandemic has been demonstrated again,however,we are still faced with new problems:how about the long-term safety of the fast tracked vaccines for pandemic(H1N1) 2009? Can we have better drugs to deal with the possible resistance to the current anti-viral drugs? In the time when pandemic(H1N1) 2009 seems to be controlled preliminarily,we need to think more about it.

关 键 词：流感大流行 记忆 斑疹伤寒 希波克拉底 人类流感 流行疾病 疾病鉴别 症状 

分 类 号：R511.7[医药卫生—内科学] R-09[医药卫生—临床医学]